搜索
Milestones
问
2021.12 — PM8001: obtained FDA approval for global multi-center phase II clinical trial
答
PM8001: obtained FDA approval for global multi-center phase II clinical trial
问
2021.09 — PM1003: IND approval for FIH phase I study
答
PM1003: IND approval for FIH phase I study
问
2021.07 — PM3002: entered clinical IIT studies; PM8003: IND approval for FIH phase I study
答
PM3002: entered clinical IIT studies; PM8003: IND approval for FIH phase I study
问
2021.06 — PM1016: entered clinical phase I studies
答
PM1016: entered clinical phase I studies
问
2021.05 — PM3006: the first subject was enrolled
答
PM3006: the first subject was enrolled
问
2021.04 — PM8001: entered clinical phase IIa studies
答
PM8001: entered clinical phase IIa studies
问
2021.03 — Round B financing; PM1016: IND approval for FIH phase I study; PM8002: the first subject was enrolled
答
Round B financing; PM1016: IND approval for FIH phase I study; PM8002: the first subject was enrolled
Copyright © 2022 Biotheus Inc. All Rights Reserved 粤ICP备2021122492号